CAMT
Camtek Ltd.
CAMT's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CAMT overall, supported by stronger fundamentals and stronger valuation.
CAMT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Weak |
CAMT's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is weak.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CAMT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 21x | $13.02 | -88% |
| Forward | 21x | $105 | — |
| Fair | 41x | $24.71 | -77% |
| Expensive | 70x | $42.77 | -59% |
| Current | 173x | $105 | — |
Historical ranges are pointers, not guarantees.
CAMT's PE is 173x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over CAMT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAMT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| High |
CAMT has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CAMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.95 | +712% |
| Q2 2026 | $0.61 | -78% |
| Q1 2026 | $0.85 | -67% |
| Q4 2025 | $0.94 | -61% |
| Q3 2025 | $0.90 | -58% |
| Q2 2025 | $2.72 | +39% |
| Q1 2025 | $2.60 | +48% |
| Q4 2024 | $2.41 | +50% |
| Q3 2024 | $2.16 | +32% |
CAMT's earnings per share have fallen from their peak: $0.61 over the past year, against $2.72 in mid-2025.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CAMT on earnings, with more consistent year-over-year improvement.
CAMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $133.2M | +8% |
| Q1 2026 | $121.7M | +2.5% |
| Q4 2025 | $128.1M | +9.2% |
| Q3 2025 | $126M | +12% |
| Q2 2025 | $123.3M | +20% |
| Q1 2025 | $118.6M | +22% |
| Q4 2024 | $117.3M | +32% |
| Q3 2024 | $112.3M | +40% |
CAMT's revenue has grown year over year for 11 quarters in a row: $133M last quarter, up 8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 20% | -5.5 points |
| Q1 2026 | 22% | -5.1 points |
| Q4 2025 | 25% | -2 points |
| Q3 2025 | 25% | -1.1 points |
| Q2 2025 | 26% | +0.7 points |
| Q1 2025 | 28% | +5.7 points |
| Q4 2024 | 27% | +7.3 points |
| Q3 2024 | 26% | +2.7 points |
CAMT's operating margin was 20% last quarter, down 5.5 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CAMT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CAMT on profitability, with a higher operating margin.
CAMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
CAMT's free cash flow has been positive every quarter for six years: $0 over the past year, against $0 the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CAMT on cash flow, with more consistent year-over-year improvement.
CAMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +49K shares |
| 1 year | +4.4% | +2.2M shares |
| 3 years | +5.9% | +2.9M shares |
| 5 years | +15% | +6.8M shares |
| Available history | +33% | +12.9M shares |
CAMT has 52M diluted shares, up 4.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
CAMT hasn't bought back shares in the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CAMT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CAMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 9.2x | High |
| Q1 2026 | 7.9x | High |
| Q4 2025 | 8.7x | High |
| Q3 2025 | 4.7x | High |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | 0.5x | Very low |
| Q3 2024 | 0.7x | Very low |
CAMT's net debt is about 9.2 years of its operating earnings (EBITDA), up from less than a year a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over CAMT on leverage, with a lower net debt burden relative to earnings.
CAMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.3 | Neutral |
| Stochastic | 11.0 | Oversold |
CAMT's weekly RSI is 38 (neutral) and its Stochastic is 11 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CAMT PE vs Technology Sector
| Metric | CAMT | Sector median | Relative |
|---|---|---|---|
| PE | 173x | 28x | 520% above |
| PE % | 93 | 35 | 58 pts above |
CAMT is trading at 173x earnings, a 520% premium to the Technology sector's median of 28x, though its earnings don't support one.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over CAMT on valuation relative to its sector.
CAMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $129.4 | 19% below |
| 20 week MA | $139.7 | 25% below |
| 50 week MA | $149.6 | 30% below |
| 100 week MA | $117.4 | 10% below |
| 200 week MA | $91.3 | 16% above |
CAMT has fallen below most of its moving averages, though it's still 16% above its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CAMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.8 | $21.1 | +95% |
| 2021 | $21.1 | $43.8 | +108% |
| 2022 | $43.8 | $21.7 | -50% |
| 2023 | $21.7 | $69.4 | +219% |
| 2024 | $69.4 | $82.5 | +19% |
| 2025 | $82.5 | $109.1 | +32% |
| 2026 YTD | $109.1 | $105.4 | -3.3% |
CAMT has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.